CSPG4.TNK

News alerts, weekly reports and conference planners

Company:

ImmunityBio, Sorrento

Drug class:

MCSP inhibitor

‹

›

CSPG4 overexpression	Soft Tissue Sarcoma	CSPG4 overexpression	Soft Tissue Sarcoma	CSPG4.TNK Sensitive: D – Preclinical CSPG4.TNK Sensitive : D	CSPG4.TNK Sensitive: D – Preclinical CSPG4.TNK Sensitive : D
CSPG4 overexpression	Fibrosarcoma	CSPG4 overexpression	Fibrosarcoma	CSPG4.TNK Sensitive: D – Preclinical CSPG4.TNK Sensitive : D	CSPG4.TNK Sensitive: D – Preclinical CSPG4.TNK Sensitive : D
CSPG4 overexpression	Leiomyosarcoma	CSPG4 overexpression	Leiomyosarcoma	CSPG4.TNK Sensitive: D – Preclinical CSPG4.TNK Sensitive : D	CSPG4.TNK Sensitive: D – Preclinical CSPG4.TNK Sensitive : D

Associations
(3)